Successful anti-TNFα treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis

American Journal of Transplantation

Volumn 9, Issue 4, 2009, Pages 858-861

  Leroy, S ^a   Guigonis, V ^b   Bruckner, D ^a   Emal Aglae, V ^c   Deschenes G ^d   Bensman, A ^a   Ulinski, T ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c Department of Nephrology ^*  (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Anti tumor necrosis factor treatment; Nephrotic syndrome; Posttransplant recurrence; Steroid resistance

Indexed keywords

BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GANCICLOVIR; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEFLOXACIN; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE CONTROL; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HEMORRHAGIC SHOCK; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY HEMORRHAGE; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; NEPHROTIC SYNDROME; PERIRENAL BLEEDING; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RELAPSE; REMISSION; STEROID THERAPY; CHILD; DRUG ANTAGONISM; IMMUNOLOGY; TREATMENT OUTCOME;

CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PLASMA EXCHANGE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SHOCK, HEMORRHAGIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63349096188     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02550.x     Document Type: Article

References (16)

1. Van Den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci 2004 107 : 125 136.
2. Cheong HI, Han HW, Park HW et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000 15 : 78 81.
3. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994 23 : 574 581.
4. Bakr A, Shokeir M, El-Chenawi F, El-Husseni F, Abdel-Rahman A, El-Ashry R. Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol 2003 18 : 516 520.
5. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993 21 : 251 259.
6. Raafat RH, Kalia A, Travis LB, Diven SC. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004 44 : 50 56.
7. Hubsch H, Montane B, Abitbol C et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 2005 20 : 210 216.
8. Pinto J, Lacerda G, Cameron JS, Turner DR, Bewick M, Ogg CS. Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 1981 32 : 83 89.
9. McCarthy ET, Sharma R, Sharma M et al. TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 1998 9 : 433 438.
10. Pai R, Ha H, Kirschenbaum MA, Kamanna VS. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: Mechanisms mediated by signal transduction. J Am Soc Nephrol 1996 7 : 914 923.
11. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med 2000 343 : 1044 1045.
12. Raveh D, Shemesh O, Ashkenazi YJ, Winkler R, Barak V. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol 2004 19 : 1281 1284.
13. Tomlinson L, Davies K, Wright DA, Holt S. Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor. Nephrol Dial Transplant 2006 21 : 2311 2314.
14. Verschueren P, Lensen F, Lerut E et al. Benefit of anti-TNF alpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis. Ann Rheum Dis 2003 62 : 368 369.
15. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial. Intens Care Med 2002 28 : 1434 1439.
16. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006 354 : 1961 1963.